Form 8-K - Current report:
SEC Accession No. 0001140361-25-016660
Filing Date
2025-04-30
Accepted
2025-04-30 16:16:05
Documents
16
Period of Report
2025-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048125_8k.htm   iXBRL 8-K 32977
2 EXHIBIT 10.1 ef20048125_ex10-1.htm EX-10.1 31088
3 EXHIBIT 10.2 ef20048125_ex10-2.htm EX-10.2 68334
7 image00001.jpg GRAPHIC 2226
  Complete submission text file 0001140361-25-016660.txt   305814

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atai-20250424.xsd EX-101.SCH 3973
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20250424_lab.xml EX-101.LAB 22690
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20250424_pre.xml EX-101.PRE 16546
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20048125_8k_htm.xml XML 4214
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 25895509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)